OpenBilldrug price receipt

NADAC week of 2026-10-14

LACOSAMIDE 200 MG/20 ML CUP

For 200 mL

Pharmacies pay

$16.58 filed

200 × $0.08288 per ML

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$24.07 estimated

$16.58 + $2.49 (15%) + $5.00 fee per fill = $24.07

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

LACOSAMIDE 200 MG/20 ML CUP is how the CMS NADAC file names this product. The FDA NDC Directory lists it as lacosamide, under the trade name “Lacosamide Oral Solution”.

FDA gives its dosage form as solution and its route as oral.

Its labelers, the companies named on the label, are PAI Holdings, LLC dba PAI Pharma, American Health Packaging and Kesin Pharmaceutical Corporation.

FDA lists no Established Pharmacologic Class for it.

The NADAC file of 2026-10-14 prices it under 4 NDCs (National Drug Codes); the FDA directory lists 3 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $16.58 for 200 mL (200 × $0.08288 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.

All 4 NDCs

Other strengths, forms and brands

14 other products in the NADAC file share the FDA nonproprietary name lacosamide with LACOSAMIDE 200 MG/20 ML CUP.

ProductPharmacies pay per unitMedicare per unit
LACOSAMIDE 10 MG/ML SOLUTION
generic · solution
$0.08288 per ML filed
eff. 2026-09-23 to 2026-09-30
We don’t know yet
LACOSAMIDE 50 MG TABLET
generic · tablet, film coated / tablet
$0.11859 per EA filed
eff. 2026-09-23
We don’t know yet
LACOSAMIDE 100 MG TABLET
generic · tablet, film coated / tablet
$0.17426 per EA filed
eff. 2026-09-23
We don’t know yet
LACOSAMIDE 100 MG/10 ML CUP
generic · solution
$0.08288 per ML filed
eff. 2026-09-23
We don’t know yet
LACOSAMIDE 150 MG TABLET
generic · tablet, film coated / tablet
$0.22128 per EA filed
eff. 2026-09-23
We don’t know yet
LACOSAMIDE 200 MG TABLET
generic · tablet, film coated / tablet
$0.24797 per EA filed
eff. 2026-09-23
We don’t know yet
LACOSAMIDE 200 MG/20 ML CUP this page
generic · solution
$0.08288 per ML filed
eff. 2026-09-23
We don’t know yet
MOTPOLY XR 100 MG CAPSULE
brand · capsule, extended release
$21.43011 per EA filed
eff. 2026-07-01
$20.10931 per EA filed
Part D 2024 average
MOTPOLY XR 150 MG CAPSULE
brand · capsule, extended release
$21.50185 per EA filed
eff. 2026-07-01
$20.10931 per EA filed
Part D 2024 average
MOTPOLY XR 200 MG CAPSULE
brand · capsule, extended release
$21.5109 per EA filed
eff. 2026-07-01
$20.10931 per EA filed
Part D 2024 average
VIMPAT 10 MG/ML SOLUTION
brand · solution
$2.29765 per ML filed
eff. 2026-09-23
We don’t know yet
VIMPAT 50 MG TABLET
brand · tablet, film coated
$11.82165 per EA filed
eff. 2026-09-23
We don’t know yet
VIMPAT 100 MG TABLET
brand · tablet, film coated
$18.53662 per EA filed
eff. 2026-09-23
We don’t know yet
VIMPAT 150 MG TABLET
brand · tablet, film coated
$19.64607 per EA filed
eff. 2026-09-23
We don’t know yet
VIMPAT 200 MG TABLET
brand · tablet, film coated
$19.62683 per EA filed
eff. 2026-09-23
We don’t know yet

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-07-01, 2026-09-23, 2026-09-30 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why does this page start at 200 mL?
NADAC prices this product per ML. The FDA NDC Directory’s package description gives 200 mL in one package for the 3 of this product’s 4 NDCs it lists (“1 TRAY in 1 CASE (0121-4048-95) / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE (0121-4048-74)”), so the card starts at one package: 200 ML. Change it to match your prescription.